The pharmacokinetic disposition of Enrofloxacin in zebrafish by aquarium water exposure, oral and intraperitoneal administration

dc.contributor.authorSakthivel, D
dc.contributor.authorSrinivasan, MR
dc.contributor.authorKarthik Venkatesh, P
dc.contributor.authorTANUVAS
dc.date.accessioned2021-12-07T07:26:09Z
dc.date.available2021-12-07T07:26:09Z
dc.date.issued2021
dc.descriptionTNV_PIJ_2021_10(7)1211-1214en_US
dc.description.abstractZebrafish (Danio rerio) is an emerging alternative animal model used for screening pharmacological effects and safety studies. One of the bottlenecks for the lack of PK data in zebrafish is the inability to collect the volume of blood required for bioanalysis. To make zebrafish a suitable alternative animal model to mammalian species to study the PK profile of a drug, we have used the skeletal muscles as an alternative to blood for bioanalysis based on the assumption that they may exhibit an equilibrium with the concentration of drug in blood and it is easy to collect muscle after euthanasia. Hence the current study was undertaken to assess the comparative pharmacokinetic profile of enrofloxacin administered by oral route, intraperitoneal (IP) route, and mixed in aquarium water. The fishes were euthanized and the skeletal muscle was collected at various time points. An assay of Enrofloxacin in skeletal muscle was done using a validated HPLC method. The AUC (μg/g.h) values for oral, intraperitoneal and exposed water routes are 2.82, 2.91 and 4.34 respectively, Cmax (μg/g) values are 0.71, 0.64 and 0.30 respectively. The results revealed that the oral and intraperitoneal (IP) route showed a better PK profile than mixed in water for enrofloxacin. The results show that the PK of enrofloxacin administered by oral and intraperitoneal route showed the typical absorption and elimination phase, whereas enrofloxacin mixed in water did not show the absorption and elimination phase. Hence it is reasonable to conclude that zebrafish can be used as an alternative model to mammals for understanding the PK of a drug. However further studies are required to ascertain their utility as an alternative to studying PK or TK of drugs.en_US
dc.identifier.urihttps://krishikosh.egranth.ac.in/handle/1/5810178744
dc.keywordsZebrafish, enrofloxacin, pharmacokinetics, HPLCen_US
dc.language.isoEnglishen_US
dc.pages1211-1214en_US
dc.relation.ispartofseries;7
dc.subjectVeterinary Scienceen_US
dc.titleThe pharmacokinetic disposition of Enrofloxacin in zebrafish by aquarium water exposure, oral and intraperitoneal administrationen_US
dc.title.alternativeThe Pharma Innovation Journalen_US
dc.typeArticleen_US
dc.volume10en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
TNV_PIJ_2021_10(7)1211-1214.pdf
Size:
816.08 KB
Format:
Adobe Portable Document Format
Description:
TNV_PIJ_2021_10(7)1211-1214
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: